{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-014812","form_type":"8-K","ticker":"ATPC","cik":"0001713210","company_name":"Agape ATP Corp","filed_at":"2024-04-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.703018+00:00","generated_at":"2026-06-03T22:19:44.176951+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Agape ATP regains Nasdaq compliance on minimum equity rule after deficiency notice","bullets":["Received March 28 deficiency letter for failing MVLS of $35M under Rule 5550(b)(2).","Reported shareholders' equity of $4,380,863 in its 2023 10-K filed April 1.","On April 10, 2024 Nasdaq confirmed compliance with Rule 5550(b)(1), matter closed."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-014812","json":"https://secwatch.observer/filing/0001493152-24-014812.json","markdown":"https://secwatch.observer/filing/0001493152-24-014812.md","text":"https://secwatch.observer/filing/0001493152-24-014812.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1713210/000149315224014812/0001493152-24-014812-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1713210/000149315224014812/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T22:19:44.176951+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e4273f81d3f745f4ff652ef692860d2603a09ecb","claim":"Agape ATP Corp received a nasdaq compliance regained notice regarding market value (rules 5550(b)(1), 5550(b)(2)).","evidence_excerpt":"April 10, 2024, Nasdaq confirmed that the Company had regained compliance with Rule 5550(b)(1) and that this matter is now closed. 2 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AGAPE ATP CORPORATION Date: April 16, 2024 By: /s/ How Kok Choong Name: How Kok Choong Title: Director, Chairman of the Board of Directors, Chief Executive Officer, Chief Operating Officer and Secretary 3","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1713210/000149315224014812/0001493152-24-014812-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"compliance regained"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"5550(b)(1), 5550(b)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}